Topic:

Infectious Diseases

Latest Headlines

Latest Headlines

South African trial renews hopes in failed HIV vaccine combo

An HIV vaccine regimen that failed in a notable clinical trial conducted in Thailand has been given a new chance to prove itself.

Ebola update: Novavax testing nanoparticle jab, Glaxo gets EMA's advice

With several companies now expediting Ebola vaccines in an attempt to halt the spread of the deadly virus, Novavax has jumped in the race, announcing that it's using its nanoparticle vaccine technology to advance a candidate of its own.

Ebola roundup: J&J invests $200M in R&D, Glaxo says vaccine will come too late

As the Ebola outbreak continues with deadly momentum, drugmakers are working at lightning speed to develop a vaccine.

Bexsero could be cost-effective for England, model says--but not at Novartis' price

What's the value of Novartis' meningitis B vaccine, Bexsero, to the U.K.? It's a question the company and the country's government have been debating for months now, unable to come to terms on a reasonable price for the jab. But medical journal The BMJ might have an answer.

Study: Adult TB vaccine with low protection rate better than infant jab

A new study suggests that a tuberculosis vaccine with low efficacy in adolescents and adults could be more successful at reducing rates of the disease than a vaccine intended for infants.

Pfizer's meningitis B vaccine is effective when given with HPV jab

Hoping to boost its chances of FDA approval early next year, Pfizer has unveiled results from a Phase II clinical trial for its meningitis B vaccine, showing that the jab is safe and effective in adolescents when given alongside a licensed vaccine for human papillomavirus.

GSK may give Ebola vaccine to West African healthcare workers in early 2015

As the Ebola outbreak continues to ravage Liberia, Guinea and Sierra Leone, GlaxoSmithKline said Phase I trials of its experimental Ebola vaccine are expected to start in West Africa in the next few weeks, and Phase II trials are likely to begin in early 2015.

WHO: NGO mix-up caused Syrian measles vaccine deaths

According to the World Health Organization, an incorrect diluent for the measles/rubella vaccine most likely caused the recent deaths of 15 Syrian children in rural Idleb.

Inovio joins Ebola fight while WHO says a vaccine could be ready by year's end

Another vaccine hopeful is joining the fight against Ebola. Inovio Pharmaceuticals said this week that it will move its Ebola vaccine candidate into clinical trials in the first half of 2015.

Accidental poliovirus dump adds to GSK's production woes

Having begun the month by revealing new problems at its Canadian flu vaccine plant and followed that up with a fine for violating the U.S. Clean Air Act last week, GSK has now accidentally dumped live poliovirus into the Belgian sewer system.